Phase 2 Study of ALIMTA (Pemetrexed) Plus Cisplatin as First-Line Treatment of Gastric Cancer.
Phase of Trial: Phase II
Latest Information Update: 03 Jun 2015
At a glance
- Drugs Cisplatin (Primary) ; Pemetrexed (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 18 Aug 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jun 2008 The expected completion date for this trial is now 1 May 2010 as reported by ClinicalTrials.gov.
- 27 Dec 2006 New trial record.